Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 16,390,000 | 16,390,000 | 0 | $157.84M | $187.50M | 28.90% | +$29.67M |
| Biogen Inc.(BIIB) | 643,000 | 643,000 | 0 | $165.26M | $166.39M | 25.64% | +$1.13M |
| Innoviva, Inc.(INVA) | 7,277,000 | 7,277,000 | 0 | $94.53M | $116.72M | 17.99% | +$22.19M |
| Gilead Sciences, Inc.(GILD) | 920,400 | 1,075,400 | +155,000 | $68.97M | $87.12M | 13.43% | +$18.14M |
| Neurocrine Biosciences, Inc.(NBIX) | 366,000 | 470,000 | +104,000 | $41.17M | $61.93M | 9.54% | +$20.75M |
| Amarin Corp PlcADR | 10,442,453 | 24,850,623 | +14,408,170 | $9.61M | $21.62M | 3.33% | +$12.01M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 775,000 | 1,000,000 | +225,000 | $5.49M | $5.99M | 0.92% | +$503.0K |
| Vor Biopharma Inc.(VOR) | 618,000 | 618,000 | 0 | $1.31M | $1.39M | 0.21% | +$80.3K |
| Regulus Therapeutics Inc | 185,183 | 185,183 | 0 | $253.7K | $237.0K | 0.04% | -$16.7K |
| ALKERMES PLCSHS(ALKS) | 7,042,200 | 0 | -7,042,200 | $197.25M | $0 | — | -$197.25M |
| MERSANA THERAPEUTICS INCCOM | 550,000 | 0 | -550,000 | $698.5K | $0 | — | -$698.5K |